The Effects of High Fiber Rye, Compared to Refined Wheat, on Gut Microbiota Composition, Plasma Short Chain Fatty Acids, and Implications for Weight Loss and Metabolic Risk Factors (the RyeWeight Study)

Consumption of whole grain and cereal fiber have been inversely associated with body weight and obesity measures in observational studies but data from large, long-term randomized interventions are scarce. Among the cereals, rye has the highest fiber content and high rye consumption has been linked to increased production of gut fermentation products, as well as reduced risks of obesity and metabolic disease. The effects on body weight and metabolic risk factors may partly be mediated through gut microbiota and/or their fermentation products. We used data from a randomized controlled weight loss trial where participants were randomized to a hypocaloric diet rich in either high fiber rye foods or refined wheat foods for 12 weeks to investigate the effects of the intervention on gut microbiota composition and plasma short chain fatty acids, as well as the potential association with weight loss and metabolic risk markers. Rye, compared to wheat, induced some changes in gut microbiota composition, including increased abundance of the butyrate producing Agathobacter and reduced abundance of [Ruminococcus] torques group, which may be related to reductions in low grade inflammation caused by the intervention. Plasma butyrate increased in the rye group. In conclusion, intervention with high fiber rye foods induced some changes in gut microbiota composition and plasma short chain fatty acid concentration, which were associated with improvements in metabolic risk markers as a result of the intervention.

[1]  R. Landberg,et al.  Grains – a major source of sustainable protein for health , 2021, Nutrition reviews.

[2]  K. Michaëlsson,et al.  A hypocaloric diet rich in high fiber rye foods causes greater reduction in body weight and body fat than a diet rich in refined wheat: A parallel randomized controlled trial in adults with overweight and obesity (the RyeWeight study). , 2021, Clinical nutrition ESPEN.

[3]  R. Landberg,et al.  Whole Grains, Gut Microbiota, and Health-Time to Get Personal? , 2021, The Journal of nutrition.

[4]  Yulong Yin,et al.  Butyrate in Energy Metabolism: There Is Still More to Learn , 2021, Trends in Endocrinology & Metabolism.

[5]  G. Hooiveld,et al.  Minor Changes in the Composition and Function of the Gut Microbiota During a 12-Week Whole Grain Wheat or Refined Wheat Intervention Correlate with Liver Fat in Overweight and Obese Adults , 2020, The Journal of nutrition.

[6]  S. Hanash,et al.  Dietary inflammatory potential in relation to the gut microbiome: results from a cross-sectional study , 2020, British Journal of Nutrition.

[7]  S. Shab-Bidar,et al.  Whole grains, dietary fibers and the human gut microbiota: A systematic review of existing literature. , 2020, Recent patents on food, nutrition & agriculture.

[8]  A. Tjønneland,et al.  Effects of whole-grain wheat, rye, and lignan supplementation on cardiometabolic risk factors in men with metabolic syndrome: a randomized crossover trial. , 2020, The American journal of clinical nutrition.

[9]  A. Astrup,et al.  Pretreatment Prevotella-to-Bacteroides ratio and salivary amylase gene copy number as prognostic markers for dietary weight loss. , 2020, The American journal of clinical nutrition.

[10]  Qi Yang,et al.  Role of Dietary Nutrients in the Modulation of Gut Microbiota: A Narrative Review , 2020, Nutrients.

[11]  Daiwen Chen,et al.  Inter-correlated gut microbiota and SCFAs changes upon antibiotics exposure links with rapid body-mass gain in weaned piglet model. , 2019, The Journal of nutritional biochemistry.

[12]  A. Astrup,et al.  Prevotella Abundance Predicts Weight Loss Success in Healthy, Overweight Adults Consuming a Whole-Grain Diet Ad Libitum: A Post Hoc Analysis of a 6-Wk Randomized Controlled Trial. , 2019, The Journal of nutrition.

[13]  J. Holst,et al.  Circulating but not faecal short-chain fatty acids are related to insulin sensitivity, lipolysis and GLP-1 concentrations in humans , 2019, Scientific Reports.

[14]  J. Sonnenburg,et al.  Long-term dietary intervention reveals resilience of the gut microbiota despite changes in diet and weight , 2019, bioRxiv.

[15]  C. Stanton,et al.  Precision Nutrition and the Microbiome Part II: Potential Opportunities and Pathways to Commercialisation , 2019, Nutrients.

[16]  J. Hughes,et al.  The Role of the Gut Microbiome in Predicting Response to Diet and the Development of Precision Nutrition Models-Part I: Overview of Current Methods. , 2019, Advances in nutrition.

[17]  M. Marco,et al.  The Role of the Gut Microbiome in Predicting Response to Diet and the Development of Precision Nutrition Models. Part II: Results. , 2019, Advances in nutrition.

[18]  R. P. Ross,et al.  Precision Nutrition and the Microbiome, Part I: Current State of the Science , 2019, Nutrients.

[19]  A. Jefferson,et al.  The Effects of Intact Cereal Grain Fibers, Including Wheat Bran on the Gut Microbiota Composition of Healthy Adults: A Systematic Review , 2019, Front. Nutr..

[20]  A. Salonen,et al.  Randomised clinical trial: effect of low-FODMAP rye bread versus regular rye bread on the intestinal microbiota of irritable bowel syndrome patients: association with individual symptom variation , 2019, BMC Nutrition.

[21]  R. Orel,et al.  Alterations in gut microbiota composition and metabolic parameters after dietary intervention with barley beta glucans in patients with high risk for metabolic syndrome development. , 2019, Anaerobe.

[22]  T. Weir,et al.  The gut microbiota at the intersection of diet and human health , 2018, Science.

[23]  P. Theil,et al.  Impact of Diet-Modulated Butyrate Production on Intestinal Barrier Function and Inflammation , 2018, Nutrients.

[24]  R. Horst,et al.  Role of gut microbiota in chronic low‐grade inflammation as potential driver for atherosclerotic cardiovascular disease: a systematic review of human studies , 2018, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[25]  Kassem M. Makki,et al.  The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease. , 2018, Cell host & microbe.

[26]  K. Whelan,et al.  Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis. , 2018, The American journal of clinical nutrition.

[27]  K. Kristiansen,et al.  Prevotella-to-Bacteroides ratio predicts body weight and fat loss success on 24-week diets varying in macronutrient composition and dietary fiber: results from a post-hoc analysis , 2018, International Journal of Obesity.

[28]  T. R. Licht,et al.  Pre-treatment microbial Prevotella-to-Bacteroides ratio, determines body fat loss success during a 6-month randomized controlled diet intervention , 2017, International Journal of Obesity.

[29]  Baoguo Sun,et al.  Whole cereal grains and potential health effects: Involvement of the gut microbiota. , 2018, Food research international.

[30]  M. Giera,et al.  Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit , 2017, Gut.

[31]  R. L. Nielsen,et al.  Whole grain-rich diet reduces body weight and systemic low-grade inflammation without inducing major changes of the gut microbiome: a randomised cross-over trial , 2017, Gut.

[32]  D. Nielsen,et al.  Whole-Grain Rye and Wheat Affect Some Markers of Gut Health without Altering the Fecal Microbiota in Healthy Overweight Adults: A 6-Week Randomized Trial. , 2017, The Journal of nutrition.

[33]  B. Paulweber,et al.  Gut microbiota dysbiosis associated with glucose metabolism disorders and the metabolic syndrome in older adults. , 2017, Beneficial microbes.

[34]  H. Fukui Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation? , 2016, Inflammatory Intestinal Diseases.

[35]  F. Bäckhed,et al.  Diet–microbiota interactions as moderators of human metabolism , 2016, Nature.

[36]  Paul J. McMurdie,et al.  DADA2: High resolution sample inference from Illumina amplicon data , 2016, Nature Methods.

[37]  J. Kirwan,et al.  A high-throughput method for liquid chromatography-tandem mass spectrometry determination of plasma alkylresorcinols, biomarkers of whole grain wheat and rye intake. , 2016, Analytical biochemistry.

[38]  J. Havlík,et al.  Reclassification of Eubacterium rectale (Hauduroy et al. 1937) Prévot 1938 in a new genus Agathobacter gen. nov. as Agathobacter rectalis comb. nov., and description of Agathobacter ruminis sp. nov., isolated from the rumen contents of sheep and cows. , 2016, International journal of systematic and evolutionary microbiology.

[39]  C. Borchers,et al.  An isotope-labeled chemical derivatization method for the quantitation of short-chain fatty acids in human feces by liquid chromatography-tandem mass spectrometry. , 2015, Analytica chimica acta.

[40]  A. Ross,et al.  Whole-grain and blood lipid changes in apparently healthy adults: a systematic review and meta-analysis of randomized controlled studies. , 2015, The American journal of clinical nutrition.

[41]  S. Collins A role for the gut microbiota in IBS , 2014, Nature Reviews Gastroenterology &Hepatology.

[42]  W. D. de Vos,et al.  The first 1000 cultured species of the human gastrointestinal microbiota , 2014, FEMS microbiology reviews.

[43]  T. Wolever,et al.  Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans , 2014, Nutrition & Diabetes.

[44]  Patrice D Cani Metabolism in 2013: The gut microbiota manages host metabolism , 2014, Nature Reviews Endocrinology.

[45]  R. Christensen,et al.  Whole grain and body weight changes in apparently healthy adults: a systematic review and meta-analysis of randomized controlled studies. , 2013, The American journal of clinical nutrition.

[46]  I. Martínez,et al.  In vitro characterization of the impact of selected dietary fibers on fecal microbiota composition and short chain fatty acid production. , 2013, Anaerobe.

[47]  S. Rane,et al.  Beneficial Metabolic Effects of a Probiotic via Butyrate-induced GLP-1 Hormone Secretion* , 2013, The Journal of Biological Chemistry.

[48]  J. Clemente,et al.  The Long-Term Stability of the Human Gut Microbiota , 2013 .

[49]  Susan Holmes,et al.  phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data , 2013, PloS one.

[50]  Pelin Yilmaz,et al.  The SILVA ribosomal RNA gene database project: improved data processing and web-based tools , 2012, Nucleic Acids Res..

[51]  Simin Liu,et al.  Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. , 2012, The Journal of nutrition.

[52]  Patrice D Cani,et al.  Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity , 2012, Gut microbes.

[53]  Hua V. Lin,et al.  Butyrate and Propionate Protect against Diet-Induced Obesity and Regulate Gut Hormones via Free Fatty Acid Receptor 3-Independent Mechanisms , 2012, PloS one.

[54]  P. Bork,et al.  Enterotypes of the human gut microbiome , 2011, Nature.

[55]  C. Seal,et al.  Whole Grains and Health, Evidence from Observational and Intervention Studies , 2010 .

[56]  A. Schwiertz,et al.  Microbiota and SCFA in Lean and Overweight Healthy Subjects , 2010, Obesity.

[57]  P. Åman,et al.  Alkylresorcinols as biomarkers of whole-grain wheat and rye intake: plasma concentration and intake estimated from dietary records. , 2008, The American journal of clinical nutrition.

[58]  J. Tiedje,et al.  Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy , 2007, Applied and Environmental Microbiology.

[59]  N. Rifai,et al.  CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice Report From the Laboratory Science Discussion Group , 2004, Circulation.

[60]  Sidney C. Smith,et al.  MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION , 2003 .

[61]  Gary L Myers,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.